Impact of Early Proteinuria Reduction in Glomerular Disease and Decline of Kidney Function: A Retrospective Cohort.

chronic kidney disease glomerular disease proteinuria

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
10 Oct 2022
Historique:
received: 18 07 2022
revised: 23 09 2022
accepted: 30 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 15 10 2022
Statut: epublish

Résumé

Background: In glomerular disease, the degree of proteinuria is closely related to the progression of chronic kidney disease, and its reduction is associated with a slower decline in the glomerular filtration rate (eGFR) and consequent improvement in the renal prognosis. The aim of this study was to evaluate the impact of proteinuria reduction on the decline of the eGFR in patients with glomerular disease, during the first year after the diagnosis. Methods: This was a retrospective analysis of patients with primary glomerular disease, followed at the Nephrology Department of Centro Hospitalar Universitário Lisboa Norte, during 2019. We analyzed demographic, clinical and laboratorial characteristics (creatinine, GFR, urine analysis and quantification of proteinuria determined by the proteinuria/creatinuria ratio, in the first morning urine or a 24 h urine sample). The outcome assessed was the decline in renal function, defined as a reduction in the GFR ≥ 25%, during the follow-up period. Results: We analyzed 197 patients with glomerular disease, with a mean age of 41.7 ± 19.7 years and follow-up time of 6.5 ± 5.3 years. At the time of the diagnosis, the eGFR was 81.5 ± 49.8 mL/min/1.73 m2 and proteinuria was 3.5 g/24 h (IQR 5.8). At one-year follow-up, median proteinuria was 0.9 g/24 h (IQR 2.4). At the end of the follow-up, mean eGFR was 72.1 ± 43.3 mL/min/1.73 m2. Proteinuria (p = 0.435) and the eGFR (p = 0.880) at the time of diagnosis did not correlate with long-term decline in the eGFR. Proteinuria < 1 g/24 h (HR 0.45 (95% CI 0.25−0.83) p = 0.011) after the first year was protective against long-term decline in the eGFR. It maintained this association with the long-term eGFR decline, independently of the duration of the follow-up (HR 0.30 (95% CI 0.17−0.52) p < 0.001). Conclusions: Proteinuria reduction to lower than 1 g/24 h, during the first year after diagnosis, was a protective factor for the long-term decline of kidney function, having a more important role than proteinuria or the GFR at the time of the diagnosis.

Identifiants

pubmed: 36233832
pii: jcm11195968
doi: 10.3390/jcm11195968
pmc: PMC9572802
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Sci Rep. 2021 Apr 22;11(1):8786
pubmed: 33888746
J Am Soc Nephrol. 2006 Jul;17(7):2034-47
pubmed: 16738019
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8
pubmed: 28236831
BMC Nephrol. 2016 Sep 08;17(1):127
pubmed: 27609359
Semin Nephrol. 2021 Sep;41(5):416-426
pubmed: 34916002
Clin J Am Soc Nephrol. 2011 Oct;6(10):2444-51
pubmed: 21852671
Kidney Int. 1997 Jan;51(1):2-15
pubmed: 8995712
Nephrol Dial Transplant. 2018 Nov 1;33(11):1942-1949
pubmed: 29509925
Lancet Diabetes Endocrinol. 2017 Aug;5(8):610-621
pubmed: 28666775
BMC Nephrol. 2020 Aug 14;21(1):345
pubmed: 32795261
Annu Rev Physiol. 2019 Feb 10;81:309-333
pubmed: 30742783
J Am Soc Nephrol. 2004 Feb;15(2):276-85
pubmed: 14747374
Lancet Diabetes Endocrinol. 2019 Feb;7(2):115-127
pubmed: 30635225
Diabetes. 1990 Jan;39(1):76-82
pubmed: 1698674
Nephrology (Carlton). 2012 Jan;17(1):68-75
pubmed: 21933307
Int J Mol Sci. 2017 Aug 04;18(8):
pubmed: 28777303
Nephrol Dial Transplant. 2016 Sep;31(9):1373-5
pubmed: 26932685
Diabetes Obes Metab. 2016 Jun;18(6):590-7
pubmed: 26936519
J Am Soc Nephrol. 1999 Jun;10(6):1204-13
pubmed: 10361858
Am J Kidney Dis. 2021 Nov;78(5):719-727
pubmed: 34051308
Lancet. 1999 Jul 31;354(9176):359-64
pubmed: 10437863
JAMA Netw Open. 2020 Jul 1;3(7):e207932
pubmed: 32672828
J Am Soc Nephrol. 2007 Dec;18(12):3177-83
pubmed: 17978307
N Engl J Med. 2006 Jan 12;354(2):131-40
pubmed: 16407508
Kidney Int. 2000 Dec;58(6):2485-91
pubmed: 11115082
Lancet Diabetes Endocrinol. 2021 Nov;9(11):755-766
pubmed: 34619106
Lancet. 2016 May 14;387(10032):2036-48
pubmed: 26921911
J Immunol Res. 2018 Sep 6;2018:2180373
pubmed: 30271792
J Nepal Health Res Counc. 2020 Nov 14;18(3):459-465
pubmed: 33210641
Kidney Int. 1998 May;53(5):1209-16
pubmed: 9573535
Am J Kidney Dis. 2021 Jun;77(6):969-983
pubmed: 33892998
Diabetes Obes Metab. 2017 Oct;19(10):1363-1370
pubmed: 28295959
Clin Chim Acta. 2019 Dec;499:54-63
pubmed: 31476302
Lancet. 2005 May 21-27;365(9473):1797-806
pubmed: 15910953

Auteurs

Filipe Marques (F)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Joana Reis (J)

Clínica Universitária de Nefrologia, Faculdade de Medicina da Universidade de Lisboa, 1649-028 Lisbon, Portugal.

Iolanda Godinho (I)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Marta Pereira (M)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Paulo Fernandes (P)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Sofia Jorge (S)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

José António Lopes (JA)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Joana Gameiro (J)

Division of Nephrology and Renal Transplantation, Department of Medicine, Centro Hospitalar Universitário Lisboa Norte, EPE, 1649-028 Lisbon, Portugal.

Classifications MeSH